Knowledge Group: What’s New for Hatch-Waxman Litigation: Exploring Trends, Updates, and Critical Issues

• Life Sciences
• CRA Insights

Analytics for clinical development strategy: Tools and opportunities

In the final part of the series, CRA’s Dr. Nick Davies presents an overview of current and emerging analytical tools and explores the opportunities for their...

• Life Sciences
• CRA Insights

World Orphan Drug Congress Europe 2024 Review: 3 Themes for sustainable and equitable access to medicines for RD patients

This year’s European World Orphan Drug Congress, attended by CRA’s Bhavesh Patel, Michele Pistollato, Charlotte Poon, Owen Male and Clara Zacharko in...

• Life Sciences
• CRA Hosted Event

• January 14, 2025
• San Francisco, CA

JP Morgan Panel Discussion - Navigating the New Landscape: What will happen with prices?

It’s been a little over two years since the Inflation Reduction Act (IRA) was enacted. During this period, the first ten products have been negotiated with...